# Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients

> **NCT00817375** · NA · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 1000 (estimated)

## Conditions studied

- Depression
- Adverse Reaction to Drug

## Interventions

- **DRUG:** SSRI treated group
- **DRUG:** non-SSRI treated group

## Key facts

- **NCT ID:** NCT00817375
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-02
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2015-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00817375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00817375, "Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00817375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*